Literature DB >> 9684146

Extended radical pancreatectomy for carcinoma of the head of the pancreas.

T Nagakawa1, I Konishi, K Ueno, T Ohta, M Kayahara, I Miyazaki.   

Abstract

BACKGROUND/AIMS: Pancreatic cancer has a poor prognosis, which is, in part due, to the unfortunately advanced stage, in which the tumor is diagnosed. Since 1973, we have utilized a unique method of extended radical pancreatectomy, using the translateral retroperitoneal approach (TRA) to facilitate combined portal resection. The advantages of this operation are described herein, for patients with carcinoma of the head of the pancreas. In addition, the problems associated with this operation are discussed.
METHODOLOGY: Survival was calculated based on type of resection, degree of invasion of the retroperitoneal tissues, degree of lymph node involvement, and cancer stage. Extensive surgery has been performed for pancreatic carcinoma 216 patients. Of these, 14 patients had carcinoma of the head of the pancreas. There were 58 patients who underwent macroscopically curative resections.
RESULTS: Only 39 patients were microscopically curative. Ten of the patients who underwent microscopically curative resections, survived for 5 years (34.0%). There were no statistically significant differences in survival based on tumor size. However, there was a significant difference in survival based on extent of invasion of the anterior capsule of the pancreas, extent of invasion of the retroperitoneal tissue, extent of lymph node involvement, cancer stage, and extent of invasion at the surgical margin of resection.
CONCLUSION: The results suggest that extended radical pancreatectomy may be indicated for the treatment of cancer of the head of the pancreas.

Entities:  

Mesh:

Year:  1998        PMID: 9684146

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Extended radical operation of pancreatic head cancer: appraisal of its clinical significance.

Authors:  De-Qing Mu; Shu-You Peng; Guo-Feng Wang
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

2.  Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma.

Authors:  E J Clark; S Connor; M A Taylor; K K Madhavan; O J Garden; R W Parks
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

3.  Validation of a prognostic nomogram in patients undergoing resection for pancreatic ductal adenocarcinoma in a UK tertiary referral centre.

Authors:  E J Clark; M A Taylor; S Connor; R O'Neill; M F Brennan; O J Garden; R W Parks
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

4.  Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head.

Authors:  Thomas J Howard; Nicholas Villanustre; Seth A Moore; John DeWitt; Julia LeBlanc; Dean Maglinte; Lee McHenry
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

Review 5.  Pancreatic Cancer: 80 Years of Surgery-Percentage and Repetitions.

Authors:  Birgir Gudjonsson
Journal:  HPB Surg       Date:  2016-10-25

6.  Acute pancreatitis in patients with pancreatic cancer: Timing of surgery and survival duration.

Authors:  Shaojun Li; Bole Tian
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.